Acadia Healthcare Company, Inc. beat EPS estimates 88% of the time across 16 reported quarters (14 beats, 2 misses), averaging +14.9% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $0.33 | $0.38 | +15.2% | Beat | |
| Q1 FY26 | $0.28 | $0.37 | +32.1% | Beat | |
| Q4 FY25 | $0.03 | $0.07 | +133.3% | Beat | Q4 FY25 call |
| Q3 FY25 | $0.67 | $0.72 | +7.5% | Beat | |
| Q2 FY25 | $0.71 | $0.83 | +16.9% | Beat | |
| Q1 FY25 | $0.35 | $0.40 | +14.3% | Beat | |
| Q4 FY24 | $0.72 | $0.64 | -11.1% | Miss | |
| Q3 FY24 | $0.90 | $0.91 | +1.1% | Beat | |
| Q2 FY24 | $0.88 | $0.91 | +3.4% | Beat | |
| Q1 FY24 | $0.80 | $0.84 | +5.0% | Beat | |
| Q4 FY23 | $0.80 | $0.85 | +6.3% | Beat | |
| Q3 FY23 | $0.88 | $0.91 | +3.4% | Beat |
Back to ACHC overview · ACHC holders · ACHC KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.